vs
Side-by-side financial comparison of Mama's Creations, Inc. (MAMA) and ARS Pharmaceuticals, Inc. (SPRY). Click either name above to swap in a different company.
Mama's Creations, Inc. is the larger business by last-quarter revenue ($47.3M vs $28.1M, roughly 1.7× ARS Pharmaceuticals, Inc.). Mama's Creations, Inc. runs the higher net margin — 1.1% vs -147.1%, a 148.3% gap on every dollar of revenue. On growth, Mama's Creations, Inc. posted the faster year-over-year revenue change (50.0% vs -67.6%).
Mama's Creations, Inc. is a U.S.-based food manufacturing enterprise that produces a wide portfolio of refrigerated ready-to-eat and heat-and-serve food products, including Italian-style meatballs, sausages, pasta dishes, and other prepared meals. It mainly distributes its offerings to grocery retailers, mass merchandisers and foodservice partners across the United States, focusing on convenient, high-quality comfort food for daily consumer demand.
ARS Pharmaceuticals, Inc. is a late-stage biopharmaceutical firm specializing in the development and commercialization of novel therapies for severe allergic reactions, most notably needle-free epinephrine delivery solutions for anaphylaxis. It primarily operates in the North American market, catering to both pediatric and adult patient groups at risk of life-threatening allergic responses.
MAMA vs SPRY — Head-to-Head
Income Statement — Q3 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $47.3M | $28.1M |
| Net Profit | $540.0K | $-41.3M |
| Gross Margin | 23.6% | — |
| Operating Margin | 1.7% | -147.6% |
| Net Margin | 1.1% | -147.1% |
| Revenue YoY | 50.0% | -67.6% |
| Net Profit YoY | 31.7% | -182.8% |
| EPS (diluted) | $0.01 | $-0.41 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $47.3M | $28.1M | ||
| Q3 25 | $35.2M | $32.5M | ||
| Q2 25 | $35.3M | $15.7M | ||
| Q1 25 | $33.6M | $8.0M | ||
| Q4 24 | $31.5M | $86.6M | ||
| Q3 24 | $28.4M | $2.1M | ||
| Q2 24 | $29.8M | $500.0K | ||
| Q1 24 | $26.7M | $0 |
| Q4 25 | $540.0K | $-41.3M | ||
| Q3 25 | $1.3M | $-51.2M | ||
| Q2 25 | $1.2M | $-44.9M | ||
| Q1 25 | $1.6M | $-33.9M | ||
| Q4 24 | $410.0K | $49.9M | ||
| Q3 24 | $1.1M | $-19.1M | ||
| Q2 24 | $553.0K | $-12.5M | ||
| Q1 24 | $1.4M | $-10.3M |
| Q4 25 | 23.6% | — | ||
| Q3 25 | 24.9% | — | ||
| Q2 25 | 26.1% | — | ||
| Q1 25 | 27.0% | — | ||
| Q4 24 | 22.6% | — | ||
| Q3 24 | 24.2% | — | ||
| Q2 24 | 25.0% | — | ||
| Q1 24 | 29.3% | — |
| Q4 25 | 1.7% | -147.6% | ||
| Q3 25 | 4.8% | -163.7% | ||
| Q2 25 | 4.5% | -302.9% | ||
| Q1 25 | 5.7% | -466.3% | ||
| Q4 24 | 1.8% | 54.5% | ||
| Q3 24 | 5.7% | -1051.6% | ||
| Q2 24 | 2.6% | -3068.0% | ||
| Q1 24 | 7.4% | — |
| Q4 25 | 1.1% | -147.1% | ||
| Q3 25 | 3.6% | -157.4% | ||
| Q2 25 | 3.5% | -285.6% | ||
| Q1 25 | 4.8% | -425.7% | ||
| Q4 24 | 1.3% | 57.7% | ||
| Q3 24 | 4.0% | -925.0% | ||
| Q2 24 | 1.9% | -2503.2% | ||
| Q1 24 | 5.3% | — |
| Q4 25 | $0.01 | $-0.41 | ||
| Q3 25 | $0.03 | $-0.52 | ||
| Q2 25 | $0.03 | $-0.46 | ||
| Q1 25 | $0.04 | $-0.35 | ||
| Q4 24 | $0.01 | $0.52 | ||
| Q3 24 | $0.03 | $-0.20 | ||
| Q2 24 | $0.01 | $-0.13 | ||
| Q1 24 | $0.03 | $-0.11 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $18.1M | $245.0M |
| Total DebtLower is stronger | — | $96.4M |
| Stockholders' EquityBook value | $49.6M | $114.3M |
| Total Assets | $84.0M | $327.7M |
| Debt / EquityLower = less leverage | — | 0.84× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $18.1M | $245.0M | ||
| Q3 25 | $9.4M | $288.2M | ||
| Q2 25 | $12.0M | $240.1M | ||
| Q1 25 | $7.2M | $275.7M | ||
| Q4 24 | $9.3M | $314.0M | ||
| Q3 24 | $7.4M | $204.6M | ||
| Q2 24 | $13.0M | $218.7M | ||
| Q1 24 | $11.0M | $223.6M |
| Q4 25 | — | $96.4M | ||
| Q3 25 | — | $96.2M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $0 | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $49.6M | $114.3M | ||
| Q3 25 | $29.6M | $147.7M | ||
| Q2 25 | $26.4M | $192.3M | ||
| Q1 25 | $24.9M | $229.0M | ||
| Q4 24 | $23.0M | $256.8M | ||
| Q3 24 | $22.3M | $201.0M | ||
| Q2 24 | $20.3M | $215.2M | ||
| Q1 24 | $19.6M | $223.9M |
| Q4 25 | $84.0M | $327.7M | ||
| Q3 25 | $51.2M | $372.8M | ||
| Q2 25 | $52.7M | $313.5M | ||
| Q1 25 | $47.1M | $327.3M | ||
| Q4 24 | $47.9M | $351.2M | ||
| Q3 24 | $43.0M | $217.6M | ||
| Q2 24 | $47.2M | $222.0M | ||
| Q1 24 | $45.1M | $227.6M |
| Q4 25 | — | 0.84× | ||
| Q3 25 | — | 0.65× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.00× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $3.9M | $-43.5M |
| Free Cash FlowOCF − Capex | $3.7M | — |
| FCF MarginFCF / Revenue | 7.8% | — |
| Capex IntensityCapex / Revenue | 0.4% | 0.0% |
| Cash ConversionOCF / Net Profit | 7.16× | — |
| TTM Free Cash FlowTrailing 4 quarters | $6.0M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $3.9M | $-43.5M | ||
| Q3 25 | $-1.7M | $-47.0M | ||
| Q2 25 | $6.0M | $-39.6M | ||
| Q1 25 | $-857.0K | $-40.7M | ||
| Q4 24 | $4.8M | $42.0M | ||
| Q3 24 | $-2.4M | $-14.5M | ||
| Q2 24 | $3.6M | $-7.3M | ||
| Q1 24 | $6.7M | $-6.7M |
| Q4 25 | $3.7M | — | ||
| Q3 25 | $-2.2M | $-47.2M | ||
| Q2 25 | $5.5M | $-39.6M | ||
| Q1 25 | $-930.0K | $-40.8M | ||
| Q4 24 | $2.5M | $41.7M | ||
| Q3 24 | $-4.0M | $-14.6M | ||
| Q2 24 | $2.5M | $-7.3M | ||
| Q1 24 | $6.6M | $-6.8M |
| Q4 25 | 7.8% | — | ||
| Q3 25 | -6.2% | -145.4% | ||
| Q2 25 | 15.5% | -252.2% | ||
| Q1 25 | -2.8% | -512.1% | ||
| Q4 24 | 8.0% | 48.2% | ||
| Q3 24 | -14.1% | -706.3% | ||
| Q2 24 | 8.4% | -1463.4% | ||
| Q1 24 | 24.8% | — |
| Q4 25 | 0.4% | 0.0% | ||
| Q3 25 | 1.5% | 0.6% | ||
| Q2 25 | 1.5% | 0.3% | ||
| Q1 25 | 0.2% | 1.1% | ||
| Q4 24 | 7.2% | 0.3% | ||
| Q3 24 | 5.6% | 6.8% | ||
| Q2 24 | 3.8% | 7.6% | ||
| Q1 24 | 0.4% | — |
| Q4 25 | 7.16× | — | ||
| Q3 25 | -1.31× | — | ||
| Q2 25 | 4.85× | — | ||
| Q1 25 | -0.54× | — | ||
| Q4 24 | 11.71× | 0.84× | ||
| Q3 24 | -2.10× | — | ||
| Q2 24 | 6.58× | — | ||
| Q1 24 | 4.79× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
MAMA
Segment breakdown not available.
SPRY
| Products | $20.3M | 72% |
| Other | $7.8M | 28% |
